Inflammatory signals regulate IL-15 in response to lymphodepletion

Journal of Immunology

Volumn 196, Issue 11, 2016, Pages 4544-4552

  Anthony, Scott M ^a,b   Rivas, Sarai C ^b   Colpitts, Sara L ^c   Howard, Megan E ^b   Stonier, Spencer W ^a,b   Schluns, Kimberly S ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; INTERFERON; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; THY 1 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; INFLAMMATION; KNOCKOUT MOUSE; LYMPHOCYTE DEPLETION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPENIA; MACROPHAGE; MEMORY T LYMPHOCYTE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL DEPLETION; UPREGULATION; WHOLE BODY RADIATION; ANIMAL; C57BL MOUSE; DISEASE MODEL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION;

ANIMALS; DISEASE MODELS, ANIMAL; INFLAMMATION; INTERLEUKIN-15; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; LYMPHOPENIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 84975108664     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600219     Document Type: Article

References (49)

1. Sandau, M. M., C. J. Winstead, and S. C. Jameson. 2007. IL-15 is required for sustained lymphopenia-driven proliferation and accumulation of CD8 T cells. J. Immunol. 179: 120-125.
2. Dudley, M. E., J. C. Yang, R. Sherry, M. S. Hughes, R. Royal, U. Kammula, P. F. Robbins, J. Huang, D. E. Citrin, S. F. Leitman, et al. 2008. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J. Clin. Oncol. 26: 5233-5239.
3. + T cells. J. Exp. Med. 202: 907-912.
4. Dudley, M. E., J. R. Wunderlich, J. C. Yang, R. M. Sherry, S. L. Topalian, N. P. Restifo, R. E. Royal, U. Kammula, D. E. White, S. A. Mavroukakis, et al. 2005. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J. Clin. Oncol. 23: 2346-2357.
5. Bracci, L., F. Moschella, P. Sestili, V. La Sorsa, M. Valentini, I. Canini, S. Baccarini, S. Maccari, C. Ramoni, F. Belardelli, and E. Proietti. 2007. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration. Clin. Cancer Res. 13: 644-653.
6. Koike, N., S. Pilon-Thomas, and J. J. Mulé. 2008. Nonmyeloablative chemotherapy followed by T-cell adoptive transfer and dendritic cell-based vaccination results in rejection of established melanoma. J. Immunother. 31: 402-412.
7. Oelert, T., M. Papatriantafyllou, G. Pougialis, G. J. Hämmerling, B. Arnold, and T. Schuler. 2010. Irradiation and IL-15 promote loss of CD8 T-cell tolerance in response to lymphopenia. Blood 115: 2196-2202.
8. + T cells via TLR4 signaling. J. Clin. Invest. 117: 2197-2204.
9. Bergamaschi, C., J. Bear, M. Rosati, R. K. Beach, C. Alicea, R. Sowder, E. Chertova, S. A. Rosenberg, B. K. Felber, and G. N. Pavlakis. 2012. Circulating IL-15 exists as heterodimeric complex with soluble IL-15Ra in human and mouse serum. Blood 120: e1-e8. Available at: http://www.bloodjournal.org/content/120/1/e1.
10. Rubinstein, M. P., M. Kovar, J. F. Purton, J. H. Cho, O. Boyman, C. D. Surh, and J. Sprent. 2006. Converting IL-15 to a superagonist by binding to soluble IL-15Ralpha. Proc. Natl. Acad. Sci. USA 103: 9166-9171.
11. Stoklasek, T. A., K. S. Schluns, and L. Lefrançois. 2006. Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo. J. Immunol. 177: 6072-6080.
12. Anthony, S. M., M. E. Howard, Y. Hailemichael, W. W. Overwijk, and K. S. Schluns. 2015. Soluble interleukin-15 complexes are generated in vivo by type I interferon dependent and independent pathways. PLoS One 10: e0120274.
13. + T cell subsets. Immunity 31: 811-822.
14. + cells in a spontaneous breast cancer model. BMC Cancer 15: 293.
15. Clausen, B. E., C. Burkhardt, W. Reith, R. Renkawitz, and I. Förster. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8: 265-277.
16. Sauer, J. D., K. Sotelo-Troha, J. von Moltke, K. M. Monroe, C. S. Rae, S. W. Brubaker, M. Hyodo, Y. Hayakawa, J. J. Woodward, D. A. Portnoy, and R. E. Vance. 2011. The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides. Infect. Immun. 79: 688-694.
17. Lodolce, J. P., D. L. Boone, S. Chai, R. E. Swain, T. Dassopoulos, S. Trettin, and A. Ma. 1998. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9: 669-676.
18. Overwijk, W. W., A. Tsung, K. R. Irvine, M. R. Parkhurst, T. J. Goletz, K. Tsung, M. W. Carroll, C. Liu, B. Moss, S. A. Rosenberg, and N. P. Restifo. 1998. gp100/pmel 17 is a murine tumor rejection antigen: induction of self-reactive, tumoricidal T cells using high-affinity, altered peptide ligand. J. Exp. Med. 188: 277-286.
19. Muller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921.
20. Colpitts, S. L., T. A. Stoklasek, C. R. Plumlee, J. J. Obar, C. Guo, and L. Lefrançois. 2012. Cutting edge: the role of IFN-a receptor and MyD88 signaling in induction of IL-15 expression in vivo. J. Immunol. 188: 2483-2487.
21. Castillo, E. F., S. W. Stonier, L. Frasca, and K. S. Schluns. 2009. Dendritic cells support the in vivo development and maintenance of NK cells via IL-15 transpresentation. J. Immunol. 183: 4948-4956.
22. Stonier, S. W., L. J. Ma, E. F. Castillo, and K. S. Schluns. 2008. Dendritic cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation. Blood 112: 4546-4554.
23. Frasca, L., S. W. Stonier, W. W. Overwijk, and K. S. Schluns. 2010. Differential mechanisms of memory CD8 T cell maintenance by individual myeloid cell types. J. Leukoc. Biol. 88: 69-78.doi:10.1189/jlb.1209816
24. Hailemichael, Y., Z. Dai, N. Jaffarzad, Y. Ye, M. A. Medina, X. F. Huang, S. M. Dorta-Estremera, N. R. Greeley, G. Nitti, W. Peng, et al. 2013. Persistent antigen at vaccination sites induces tumor-specific CD8 T cell sequestration, dysfunction and deletion. Nat. Med. 19: 465-472.
25. + bone marrow-derived cells. Blood 103: 988-994.
26. Colpitts, S. L., S. W. Stonier, T. A. Stoklasek, S. H. Root, H. L. Aguila, K. S. Schluns, and L. Lefrançois. 2013. Transcriptional regulation of IL-15 expression during hematopoiesis. J. Immunol. 191: 3017-3024.
27. Markiewski, M. M., and J. D. Lambris. 2007. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am. J. Pathol. 171: 715-727.
28. Ishikawa, H., Z. Ma, and G. N. Barber. 2009. STING regulates intracellular DNAmediated, type I interferon-dependent innate immunity. Nature 461: 788-792.
29. Ishikawa, H., and G. N. Barber. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455: 674-678.
30. Deng, L., H. Liang, M. Xu, X. Yang, B. Burnette, A. Arina, X. D. Li, H. Mauceri, M. Beckett, T. Darga, et al. 2014. STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors. Immunity 41: 843-852.
31. Woo, S. R., M. B. Fuertes, L. Corrales, S. Spranger, M. J. Furdyna, M. Y. Leung, R. Duggan, Y. Wang, G. N. Barber, K. A. Fitzgerald, et al. 2014. STINGdependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. [Published erratum appears in 2015 Immunity 42: 199.] Immunity 41: 830-842.
32. Schluns, K. S., W. C. Kieper, S. C. Jameson, and L. Lefrançois. 2000. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat. Immunol. 1: 426-432.
33. + T cell homeostasis. J. Exp. Med. 200: 825-834.
34. Huntington, N. D., N. Legrand, N. L. Alves, B. Jaron, K. Weijer, A. Plet, E. Corcuff, E. Mortier, Y. Jacques, H. Spits, and J. P. Di Santo. 2009. IL-15 transpresentation promotes human NK cell development and differentiation in vivo. J. Exp. Med. 206: 25-34.
35. Mortier, E., T. Woo, R. Advincula, S. Gozalo, and A. Ma. 2008. IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J. Exp. Med. 205: 1213-1225.
36. + T cell O-glycan synthesis and affects trafficking. J. Clin. Invest. 124: 1013-1026.
37. Richer, M. J., L. L. Pewe, L. S. Hancox, S. M. Hartwig, S. M. Varga, and J. T. Harty. 2015. Inflammatory IL-15 is required for optimal memory T cell responses. J. Clin. Invest. 125: 3477-3490.
38. Davidoff, A. N., and B. V. Mendelow. 1993. Cell-cycle disruptions and apoptosis induced by the cyclophosphamide derivative mafosfamide. Exp. Hematol. 21: 922-927.
39. Hemendinger, R. A., and S. E. Bloom. 1996. Selective mitomycin C and cyclophosphamide induction of apoptosis in differentiating B lymphocytes compared to T lymphocytes in vivo. Immunopharmacology 35: 71-82.
40. Eriksson, D., and T. Stigbrand. 2010. Radiation-induced cell death mechanisms. Tumour Biol. 31: 363-372.
41. Brenchley, J. M., D. A. Price, T. W. Schacker, T. E. Asher, G. Silvestri, S. Rao, Z. Kazzaz, E. Bornstein, O. Lambotte, D. Altmann, et al. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12: 1365-1371.
42. Do, J. S., and B. Min. 2009. IL-15 produced and trans-presented by DCs underlies homeostatic competition between CD8 and gammadelta T cells in vivo. Blood 113: 6361-6371.
43. Mattei, F., G. Schiavoni, F. Belardelli, and D. F. Tough. 2001. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 167: 1179-1187.
44. + T cells in vivo by IL-15. Immunity 8: 591-599.
45. + T cell numbers, effector function, and antitumor activity. J. Immunol. 182: 7398-7407.
46. + T central-memory cell survival but not T effector-memory cell development. J. Immunol. 187: 5170-5182.
47. Obar, J. J., and L. Lefrançois. 2010. Early signals during CD8 T cell priming regulate the generation of central memory cells. J. Immunol. 185: 263-272.
48. +) T cell fates via the graded expression of T-bet transcription factor. Immunity 27: 281-295.
49. + T-cell subsets during contraction of the immune response. Blood 112: 3704-3712.